# Response to Relapse in Office-Based Opioid Treatment Trial

> **NCT03812107** · NA · TERMINATED · sponsor: **Boston Medical Center** · enrollment: 115 (actual)

## Conditions studied

- Opioid-use Disorder

## Interventions

- **OTHER:** Moderate Treatment Approach
- **OTHER:** Intensive Treatment Approach

## Key facts

- **NCT ID:** NCT03812107
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-07
- **Primary completion:** 2020-03-12
- **Final completion:** 2020-03-12
- **Target enrollment:** 115 (ACTUAL)
- **Why stopped:** The study was stopped due to COVID-19 as it interfered with the study intervention.
- **Last updated:** 2022-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03812107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03812107, "Response to Relapse in Office-Based Opioid Treatment Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03812107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*